Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$191.17 - $325.63 $3,058 - $5,210
-16 Reduced 11.76%
120 $39,000
Q4 2023

Feb 14, 2024

SELL
$160.99 - $215.69 $2,092 - $2,803
-13 Reduced 8.72%
136 $25,000
Q3 2023

Nov 13, 2023

SELL
$194.33 - $283.97 $5,052 - $7,383
-26 Reduced 14.86%
149 $29,000
Q2 2023

Aug 08, 2023

BUY
$223.05 - $302.68 $39,033 - $52,969
175 New
175 $49,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.